Summary of Purpose
This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.Read More →
The following dates are available for this trial. Trial information last updated on 25 July 2017.
|28 Jul 2016||25 Jul 2017||30 May 2018||30 Dec 2019||1 Sep 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Sun U Kwon, MD